Latest Breaking News On - Business development staff - Page 11 : comparemela.com
Molecular Diagnostics at the Point of Care 2021-2025: Global Industry Assessment by Application, Technology, Place, Product and Country
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Global Respiratory Infection Diagnostic Market Report 2021: COVID-19 Breaks open Point of Care Markets / Technologies Compete for Diagnostic Gold Rush
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Global Respiratory Infection Diagnostic Market Report 2021: COVID-19 Breaks open Point of Care Markets / Technologies Compete for Diagnostic Gold Rush
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
8.2.3 Wellness Hurts
8.3 Instrumentation and Automation
8.3.2 The Shrinking Machine
8.4 Diagnostic Technology Development
8.4.2 POCT/Self Testing as a Disruptive Force
8.4.3 The Genetics Play - One Test for All Known Infections
8.4.4 Antibiotic Resistance Genes - Simplifying Diagnostics
9 Molecular Dx - Infectious Disease Recent Developments
9.1 Recent Developments - Importance and How to Use This Section
9.1.1 Importance of These Developments
9.1.2 How to Use This Section
9.2 Roche to Acquire GenMark Diagnostics for $1.8B
9.3 Lucira Health Focuses on User Friendly Approach to Home Testing
9.4 Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO
9.5 Fluidigm Plans Durable Diagnostics, Clinical Business
9.6 Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M
7 Molecular Diagnostics Recent Developments
7.1 Recent Developments - Importance and How to Use This Section
7.1.1 Importance of These Developments
7.1.2 How to Use This Section
7.2 Nucleix to Invest in Early-Stage Lung Cancer Dx
7.3 Invitae to Acquire Genosity for $200M
7.4 Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test
7.5 Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience
7.6 Natera Revenues Grow 35 Percent
7.7 AnchorDx Closes $40M Financing Round
7.8 Exact Sciences Strategy for End-to-End Cancer Testing
7.9 Genomics England: Whole Genome Sequencing for Cancer Patients to Launch
7.10 Singlera Genomics Closes $150M Funding for Cancer Screening
7.11 Biocartis GeneproDx, Endpoint Health Collaborate on Tests for Idylla Platform